Delving into the Latest Updates on Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd. with Synapse

Overview

Tags

Other Diseases

Nervous System Diseases

Endocrinology and Metabolic Disease

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Infectious Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

κ opioid receptor x μ opioid receptor	1
DNA	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Approved

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

(S)-Ornidazole Disodium Phosphate ( DNA )	Bacterial Infections More	Approved
Nalbuphine Hydrochloride ( κ opioid receptor x μ opioid receptor )	-	Phase 1